Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Avoid Analogic Corporation (ALOG)?

Page 1 of 2

Is it smart to be bullish on Analogic Corporation (NASDAQ:ALOG)?

In the financial world, there are many indicators shareholders can use to monitor stocks. A pair of the most under-the-radar are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best fund managers can trounce their index-focused peers by a superb amount (see just how much).

Just as crucial, positive insider trading sentiment is a second way to analyze the marketplace. Just as you’d expect, there are many reasons for an executive to cut shares of his or her company, but only one, very simple reason why they would initiate a purchase. Several academic studies have demonstrated the useful potential of this strategy if investors understand what to do (learn more here).

Keeping this in mind, we’re going to discuss the newest info about Analogic Corporation (NASDAQ:ALOG).

Hedge fund activity in Analogic Corporation (NASDAQ:ALOG)

At the end of the second quarter, a total of 8 of the hedge funds we track were bullish in this stock, a change of -43% from the previous quarter. With hedgies’ capital changing hands, there exists an “upper tier” of key hedge fund managers who were boosting their stakes meaningfully.

Analogic Corporation (NASDAQ:ALOG)When using filings from the hedgies we track, Chuck Royce’s Royce & Associates had the most valuable position in Analogic Corporation (NASDAQ:ALOG), worth close to $41.6 million, comprising 0.1% of its total 13F portfolio. The second largest stake is held by Jim Simons of Renaissance Technologies, with a $7.1 million position; less than 0.1%% of its 13F portfolio is allocated to the company. Other hedge funds that are bullish include Israel Englander’s Millennium Management, Cliff Asness’s AQR Capital Management and Ken Gray and Steve Walsh’s Bryn Mawr Capital.

Judging by the fact that Analogic Corporation (NASDAQ:ALOG) has experienced a fall in interest from the top-tier hedge fund industry, logic holds that there lies a certain “tier” of money managers that elected to cut their positions entirely heading into Q2. Interestingly, Andy Redleaf’s Whitebox Advisors cut the largest position of all the hedgies we key on, valued at an estimated $0.7 million in call options.. Matthew Hulsizer’s fund, PEAK6 Capital Management, also sold off its call options., about $0.7 million worth. These bearish behaviors are important to note, as aggregate hedge fund interest fell by 6 funds heading into Q2.

What have insiders been doing with Analogic Corporation (NASDAQ:ALOG)?

Insider buying is most useful when the company we’re looking at has seen transactions within the past six months. Over the last 180-day time frame, Analogic Corporation (NASDAQ:ALOG) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Analogic Corporation (NASDAQ:ALOG). These stocks are Cubic Corporation (NYSE:CUB), ESCO Technologies Inc. (NYSE:ESE), Ion Geophysical Corp (NYSE:IO), II-VI, Inc. (NASDAQ:IIVI), and MTS Systems Corporation (NASDAQ:MTSC). This group of stocks belong to the scientific & technical instruments industry and their market caps are closest to ALOG’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!